Group A rotaviruses are major intestinal pathogens that express potential a4b1 and a4b7 integrin ligand sequences Leu-Asp-Val and Leu-Asp-Ile in their outer capsid protein VP7, and Ile-Asp-Ala in their spike protein VP4. Monkey rotavirus SA11 can use recombinant a4b1 as a cellular receptor. In this study a new potential a4b1, a4b7 and a9b1 integrin ligand sequence, Tyr-Gly-Leu, was identified in VP4. It was shown that several human and monkey rotaviruses bound a4b1 and a4b7, but not a9b1. Binding to a4b1 mediated the infectivity and growth of monkey rotaviruses, and binding to a4b7 mediated their infectivity. A porcine rotavirus interacted with a4 integrins at a post-binding stage to facilitate infection. Activation of a4b1 increased rotavirus infectivity. Cellular treatment with peptides containing the a4 integrin ligand sequences Tyr-Gly-Leu and Ile-Asp-Ala eliminated virus binding to a4 integrins and infectivity. In contrast, rotavirus recognition of a4 integrins was unaffected by a peptide containing the sequence Leu-Asp-Val or by a mutation in the VP7 Leu-Asp-Val sequence. VP4 involvement in rotavirus recognition of a4b1 was demonstrated with rotavirus reassortants. Swapping and point mutagenesis of a4 surface loops showed that rotaviruses required the same a4 residues and domains for binding as the natural a4 integrin ligands: mucosal addressin cell adhesion molecule-1, fibronectin and vascular cell adhesion molecule-1. Several rotaviruses are able to use a4b7 and a4b1 for cell binding or entry, through the recognition of the same a4-subunit domains as natural a4 ligands.
INTRODUCTION
Rotaviruses are a major cause of gastroenteritis through intestinal epithelial cell infection and they can spread extraintestinally Mossel & Ramig, 2003) . Many group A rotaviruses bind to the a2b1 integrin via its ligand sequence Asp-Gly-Glu (DGE), which projects from the VP5* subunit of the spike protein VP4. These viruses use the outer capsid protein VP7 to interact with integrins axb2 and avb3 during cell entry Dormitzer et al., 2004; Graham et al., 2003; Guerrero et al., 2000; Hewish et al., 2000) . Rotavirus infectivity in intestinal and kidney cell lines is inhibited by at least 65 % with combinations of antibodies or ligand peptides directed to these integrins Graham et al., 2003 Graham et al., , 2004 Guerrero et al., 2000) . Integrins are heterodimeric cell adhesion molecules (Hynes, 2002) that act as receptors for many viruses (Triantafilou et al., 2001) . Cellular sialic acids, gangliosides and other carbohydrates are also implicated as rotavirus receptors (Ciarlet et al., 2002; Rolsma et al., 1998) . Heat-shock protein 70 has a role in rotavirus cell entry (Lopez & Arias, 2004) .
Integrins and their natural ligands are essential for epithelial cell adhesion to the extracellular matrix, immune responses and lymphocyte trafficking (Hynes, 2002; Mittelbrunn et al., 2004) . The a4 integrin subunit pairs with either b1 or b7 to form part of a subfamily that also includes a9b1 (Hynes, 2002) . The a4b1 integrin is expressed on mesenchymal cells in the intestinal lamina propria. These cells are important for mucosal inflammation and repair (Choy et al., 1990; Pender et al., 2000; Powell et al., 1999) . The a4 integrins are highly expressed on B and T lymphocytes, dendritic cells, (Hynes, 2002; Pender et al., 2000) . Intestinal epithelial cells express a9b1 (Basora et al., 1998; Yokosaki et al., 1999) . The intestinal homing receptor, a4b7, binds to mucosal addressin cell adhesion molecule-1 (MAdCAM-1) on post-capilliary venules. In contrast, a4b1 preferentially engages fibronectin and vascular cell adhesion molecule-1 (VCAM-1) to induce intestinal mesenchymal cell migration (Pender et al., 2000) and control B-and T-lymphocyte development, proliferation and survival (Mittelbrunn et al., 2004; Tidswell et al., 1997) .
Protection from rotavirus reinfection is primarily mediated by rotavirus-specific intestinal immunoglobulin A (IgA) in animals (Franco & Greenberg, 1999) , and correlates with this IgA in humans (Coulson et al., 1992) . The presence of rotavirus-specific, antibody-secreting cells in the intestine correlates with their detection in blood (Brown et al., 2000; Yuan et al., 1996) . Human rotavirus-specific, antibodysecreting B cells and CD4
+ T cells predominantly express a4b7 (Gonzalez et al., 2003; Rott et al., 1997) . In mice, rotavirus-specific B cells require a4b7 for protective immunity Youngman et al., 2002) , and memory T cells strongly express a4b7 Rott et al., 1997) . Thus, effective rotavirus immune responses depend on MAdCAM-1 recognition by lymphocytes expressing a4b7.
Potential ligand sequences for a4b1 and a4b7 are found in the outer capsid proteins of most rotaviruses. The sequences Ile-Asp-Ala (IDA) and Leu-Asp-Val (LDV) in fibronectin that are important for a4b1 and a4b7 recognition (Chan et al., 1992; Komoriya et al., 1991; Ruegg et al., 1992; Sharma et al., 1999; Wayner & Kovach, 1992) are present in VP5* and the disintegrin-like domain of VP7, respectively. This VP7 domain also contains the sequence Leu-Asp-Ile (LDI) that is closely related to LDV Hewish et al., 2000) . Simian rotavirus SA11 binds cell surfaceexpressed a4b1, facilitating infection and replication . Mouse polyomavirus also contains LDV sequence, and uses a4b1 as an entry factor (Caruso et al., 2003) .
Two aims of this study were to determine if human and porcine rotaviruses interact with a4b1 and to detect any rotavirus recognition of a4b7. The presence in rotavirus VP5* of the Tyr-Gly-Leu (YGL) sequence used by osteopontin to bind a4 and a9 integrins (Barry et al., 2000; Green et al., 2001; Yokosaki et al., 1999) is reported here for the first time, leading to the hypothesis that this YGL sequence might mediate rotavirus recognition of a4 integrins. As a4 and a9 integrins share ligand specificity, rotavirus usage of a9b1 was examined. The roles of rotavirus IDA, LDV, LDI and YGL sequences in a4 integrin recognition were studied here for the first time in cells with demonstrable a4 expression.
Integrin subunits combine extracellularly to form a head and two legs. These domains exhibit structural rearrangements between the 'closed', low affinity conformation and the 'open', high affinity activated state (Hynes, 2002; Xiao et al., 2004) . The N-terminal~440 aa of integrin a-subunits contain regions important for ligand binding and consist of seven sequence repeats that are predicted to fold into a bpropeller domain in the integrin head (Springer, 1997) . Propeller blades are connected by loop structures. Loops that are critical for a4 adhesion to VCAM-1, fibronectin and MAdCAM-1 are grouped in the upper face of the bpropeller (Higgins et al., 2000; Irie et al., 1997; Ruiz-Velasco et al., 2000) . Another hypothesis tested here was that rotaviruses bind a4b1 through the recognition of the same a4 sequences as natural a4 ligands.
METHODS
Antibodies, proteins and peptides. Monoclonal antibodies (mAbs) P4C2 (a4), 8A2, 4B4 (b1) and MOPC21 were obtained as before (Coulson, 1997; Coulson et al., 1997; Hewish et al., 2000) . mAbs AK7 (a2) and Fib27 (b7) were purchased from Becton Dickenson PharMingen, P4G9 (a4) from Chemicon and Y9A2 (a9) from Serotec. mAb RA3-6B2 (rat anti-mouse B220) was provided by J. Allison, Dept. of Microbiology and Immunology, The University of Melbourne, Australia. BSA and fibronectin were obtained and used as described previously . Peptides Ser-ValVal-Tyr-Gly-Leu-Arg (SVVYGLR), Val-Arg-Val-Gly-Leu-Tyr-Ser (VRVGLYS), Ile-Asp-Ala-Pro-Ser (IDAPS), Ile-Glu-Ala-Pro-Ser (IEAPS), Glu-Ile-Leu-Asp-Val-Pro (EILDVP), Glu-Ile-Leu-GluVal-Pro (EILEVP), Asp-Gly-Glu-Ala (DGEA) and Gly-His-Arg-Pro (GHRP; ¢90 % pure by HPLC) were purchased from Auspep. Peptide SVVYGLR also was provided by A. Albiston, Howard Florey Institute of Experimental Physiology and Medicine, Melbourne, Australia.
Cell lines and viruses. The generation and maintenance of the cell lines utilized in this study and monitoring of their cell surface integrin expression by flow cytometry were carried out as described previously (Eto et al., 2000; Hewish et al., 2000; Higgins et al., 2000; Irie et al., 1995 Irie et al., , 1997 Londrigan et al., 2000) . The cell lines utilized were: human K562, Caco-2 and rhabdomyosarcoma (RD), hamster CHO B2 and CHO K1, and monkey MA104 cells; K562 cells transfected with cDNA encoding human integrin subunits a3 (a3-K562), a4 (a4-K562), a9 (a9-K562) and empty vector (PBJ-K562); CHO B2 cells transfected with cDNA encoding human a4 integrin-subunit (CHO B2 a4), mutant a4 in which a4-subunit loops were replaced with the corresponding a5 integrin-subunit regions R1 (residues 40-52), R2 (residues 112-131), R3a (residues 151-164), R3b (residues 181-189), R3c (residues 186-191), R4 (residues 237-247) and R5 (residues 282-288) (CHO B2 a4 R1, CHO B2 a4 R2, CHO B2 a4 R3a, CHO B2 a4 R3b, CHO B2 a4 R3c, CHO B2 a4 R4 and CHO B2 a4 R5, respectively) and human a4 and b7 (a4b7-CHO B2); CHO K1 cells transfected with cDNA encoding human a4 (CHO K1 a4) and a4 with point mutations Y120A/G130A (CHO K1 a4 Y120A/G130A), Y187A (CHO K1 a4 Y187A) and G190A (CHO K1 a4 G190A), and human a4 and b7 (a4b7-CHO K1). The presence of the expected epitopes on recombinant human a4 and b7 expressed on the cell surface was confirmed by flow cytometry using mAbs P4C2 and P4G9 for wild-type and mutant a4, respectively, and mAb Fib27 for b7. The origins of the rotaviruses that were used in this study, and their cultivation in MA104 cells, have been described previously Kirkwood et al., 1993) .
Virus binding, infectivity and growth assays. The assays used to determine the titre of infectious rotavirus bound to cells, and measure peptide and mAb inhibition of virus binding were carried out as described previously Graham et al., 2003 Graham et al., , 2004 Hewish et al., 2000; Londrigan et al., 2003) . Briefly, washed cells were incubated at 37 uC with peptides (0?5 mM) at pH 7?5 for 1 h or mAbs (10 mg ml
21
) for 2 h. This antibody concentration was determined by flow cytometry to be the lowest saturating concentration. In the presence of peptide or antibody, cells were cooled on ice for 20 min. Trypsin-activated virus (m.o.i. of 3?5 unless otherwise stated) was cooled to 4 uC and allowed to attach to cells on ice for 1 h. Cell-bound virus titres were determined by indirect immunofluorescent staining of infected MA104 cells, and expressed as focus-forming units per ml (f.f.u. ml 21 ) . The effects of peptides at 0?5 mM (unless otherwise stated), and mAbs on virus infectivity (m.o.i. of 0?02) and growth (m.o.i. of 0?35) were measured by a fluorescence focus reduction-assay Graham et al., 2004; Hewish et al., 2000; Londrigan et al., 2003) . For mock infection, cell cultures were inoculated with lysates of confluent, uninfected MA104 cells that had been trypsin-treated and diluted as for the virus infectivity activation. The error bars on the graphs presented represent the standard deviation (SD).
Flow cytometric assay of virus infectivity. The proportion of PBJ-K562 and a4-K562 cells that were rotavirus-infected was determined by flow cytometry, as these cells showed non-adherent growth. Cells (5610 5 ) that had been infected with trypsin-activated rotaviruses RRV, CRW-8, Wa or RV-5 (m.o.i. of 10) for 16 h were washed once with PBS containing 1 % (v/v) fetal calf serum (PBS/ FCS). Cells were permeabilized by methanol fixation for 7 min at 220 uC and washed with PBS/FCS. Cell-associated viral antigen was detected with rabbit antiserum to RRV, using as a negative control normal rabbit serum in which antibodies to rotavirus were present at a titre of <1 : 100 by ELISA . Cells were further processed for flow cytometry using a two-step stain. This flow cytometric method was validated using rotavirus-infected MA104 cells, by comparison with visual counting of infected cells in fixed monolayers stained by indirect immunofluorescence with the same antiserum .
RESULTS
Potential ligand sequences for a4b1, a4b7 and a9b1 in rotavirus
The YGL integrin ligand sequence was identified in 164 of 168 (98 %) of VP4 sequences in the Entrez Database (NCBI), in VP5* at aa 448-450. The YGL sequence in osteopontin binds a4b1 and a9b1, and antagonizes a4b7 binding by MAdCAM-1 (Barry et al., 2000; Green et al., 2001; Yokosaki et al., 1999) . In 60 of 156 (39 %) of rotaviruses, VP4 contains the IDA sequence in VP5* at aa 538-540. Also, in 272 of 605 (45 %) of rotaviruses, VP7 sequences contain Leu-Asp-ValThr (LDVT) at aa 237-240 and 78 % contain Leu-Asp-IleThr (LDIT) at aa 269-272 . The sequences present in rotaviruses studied here are indicated in Table 1 .
Rotavirus proteins involved in a4b1 recognition
Rotavirus binding to human a4b1 was examined using an assay developed previously that detected SA11 binding to a4b1 on K562 cells, and binding of many rotaviruses to a2b1 on a range of cell types (Graham et al., , 2004 Hewish et al., 2000; Londrigan et al., 2003) . RRV purification did not alter its binding or infectivity using a4b1 on CHO K1 cells, so clarified virus cell harvests were used as before.
Rotaviruses Wa, RV-5, SA11 and RRV that use a2b1, axb2 and avb3 for cell binding and entry also bound a4b1 (Table 1) . Strain K8 that uses a2b1, axb2 and avb3, and integrin-independent virus CRW-8 did not bind a4b1. The rotavirus strain, ST-3, does not use a2b1, axb2 or avb3, but did bind a4b1. Thus, for 5 of 7 rotaviruses, a4b1 usage correlated with that of other integrins. The two P serotype 1A rotaviruses Wa and F45 differed in their ability to bind a4b1, showing that the P type did not entirely determine a4b1 usage. Wa and RV-5 lack IDA, and Wa, RV-5 and ST-3 lack LDVT, indicating that these sequences were not essential for a4b1 binding. CRW-8 and K8 have YGL and LDIT but did not bind a4b1. However, all rotaviruses that bound a4b1 possessed YGL and LDIT.
The identity of the viral gene(s) involved in a4b1 usage was examined using laboratory-generated reassortants that contained a heterologous VP7 gene segment. Several of these reassortants were used previously to map rotavirus recognition of other integrins . In three reassortants, the a4b1-binding phenotype segregated with VP4 (Table 1) . A further three reassortants bound a4b1, consistent with the phenotypes of their parental viruses. Rotavirus usage of a4b1 did not co-segregate with any other viral gene.
Rotavirus binding to a4b1 and a4b7 depended on the ligand-binding domain of a4 and was inhibited by integrin ligand peptides
The ability of rotaviruses to bind recombinant human a4b7 was tested by comparing virus binding to CHO B2, a4-CHO B2 and a4b7-CHO B2 cells. Flow cytometric histograms of a4 expression, determined with mAb P4C2, were identical for a4-CHO B2 and a4b7-CHO B2 cells, so their cell surface levels of a4 were indistinguishable. The relative linear median fluorescence intensity (MFI) of a4 expression was calculated from these histograms, using previously described methodology , as 3?5 and 3?2, respectively. As expected, only a4b7-CHO B2 cells expressed the b7-subunit, which was detected with anti-b7 antibody Fib27. The MFI of b7 expression on a4b7-CHO B2 cells was 2?8. CHO B2 cells did not express a4 or b7, as they showed an MFI of 1?0 for these integrin subunits. a4-CHO B2 cells did not express b7 (MFI of 0?8). Similar numbers of a4-K562 cells and K562 cells transfected with a4b7 bind fibronectin CS-1 and VCAM-1 (Guerrero-Esteo et al., 1998; Munoz et al., 1997; Ruiz-Velasco et al., 2000) . Thus, alteration of the a4b1 activation state on CHO cells by b7 expression is unlikely. SA11, RRV and Wa bound to human a4 combined with hamster b1 on a4-CHO B2 cells, but bound to a higher level to a4b7-CHO B2 cells that expressed both human a4 combined with hamster b1, and human a4b7 (Fig. 1) . Thus, these viruses bound to both a4b7 and a4b1 on a4b7-CHO B2 cells. Similar results were obtained using a4b7-CHO K1 and a4-CHO K1 cells (data not shown). SA11 binding to a4-K562 cells was abolished by cellular treatment with mAb P4C2 . This antibody maps to the second and third N-terminal repeats (R2 and R3) of a4 that contain residues critical for ligand binding (Irie et al., 1995 (Irie et al., , 1997 Kamata et al., 1995) . P4C2 also eliminated RRV and Wa binding to a4-K562 cells, as virus titres bound in the presence of this antibody were indistinguishable from those bound to PBJ-K562 and a3-K562 cells (Fig. 2) . P4C2 similarly abrogated rotavirus binding to a4b7. In contrast, the function-blocking mAb Fib27 that maps to aa 176-237 of b7 (Tidswell et al., 1997) had no effect on virus binding to a4b7. Similarly, function-blocking anti-b1 antibody 4B4 that inhibited SA11 binding to MA104 cells (Coulson, 1997) did not affect RRV binding to a4b1. CRW-8 binding to CHO and K562 cells was independent of a4b1 or a4b7 and unaffected by the anti-a4 or -b7 mAbs.
Peptides containing the integrin ligand sequences present in rotaviruses were used to further define the roles of these sequences in a4 binding. Peptides used as negative controls were the same as those included in previous studies of integrin recognition of cellular ligands. Peptides inhibitory to rotavirus binding were SVVYGLR that binds a4b1 and a4b7, derived from osteopontin (Barry et al., 2000; Green *Laboratory-adapted rotaviruses are shown with strain name preceded by the species of origin. Si, Simian; Hu, human; Po, porcine. In reassortants (shown in italics), VP7 and VP4 originated from the first-and last-named virus, respectively (Lazdins et al., 1995; Nagesha et al., 1989; Nagesha & Holmes, 1991) . DSerotypes were designated previously (Ciarlet et al., 2002; Hoshino et al., 1998; Kirkwood et al., 1998) . P serotype precedes P genotype, which is shown in square brackets. dInfectious rotavirus binding to a4b1 is expressed as a percentage of the binding to PBJ-K562 cells, and positive levels of binding are in bold. PBJ-K562 cells bound 1?0610 4 -1?4610 5 f.f.u. ml 21 of virus, depending on the strain. This shows that 2-28 % of these cells bound virus, and that 0?6-8 % of input virus was bound, depending on the virus strain. Cellular treatment with mAb P4C2, as described in Fig. 3 , reduced F456SA11 binding to a4-K562 cells to 102±4 % of control, but had no effect on F456SA11 binding to PBJ-K562 cells. Therefore, the binding of F45XSA11 measured was specific for a4b1. SA11, RRV and CRW-8, but not Wa or RV-5, were shown to infect a4-K562 cells following a4b1 binding (Fig. 3) . ND, Not done. et al., 2001), and IDAPS, constituting a region of fibronectin H1 that has an indirect role in a4b1 binding. IDAPS peptide blockade of a4b1 binding to fibronectin has been proposed to result from mimicry of the EILDVP sequence in fibronectin that directly binds a4b1 and a4b7 (Chan et al., 1992; Komoriya et al., 1991; Ruegg et al., 1992; Sharma et al., 1999; Wayner & Kovach, 1992) . SVVYGLR and IDAPS eliminated SA11, RRV and Wa binding to recombinant, cell surface-expressed a4b1 and a4b7 (Fig. 2) . However, peptide EILDVP, and control peptides VRVGLYS, IEAPS and EILEVP did not affect binding of these viruses to a4 integrins. A low level of SA11 inhibition was seen with VRVGLYS. None of the peptides altered the background level of binding of CRW-8 to the transfected cells.
Infectivity and growth of some rotaviruses were mediated through a4b1 and a4b7 SA11 binding to a4b1 resulted in increased SA11 yield . The abilities of other rotaviruses to infect and replicate via a4b1 were determined. In the presence of a4b1, the number of K562 cells infected by RRV and CRW-8 (detected by flow cytometry) increased from a mean±SD of 45?3±1?9 to 56?9±2?0 % and from 0?1±0?0 to 24?7±0?4 %, respectively (Fig. 3a) . RRV and CRW-8 yields increased four-to sixfold due to a4 expression (Fig. 3b) . The negligible proportion of a4-K562 cells infected by Wa (0?2±0?1 %) was similar to that in K562 cells (0?1±0?1 %) and mock-infected cells (0?2±0?1 %), and no infectious Wa or RV-5 was produced by PBJ-K562, a3-K562 or a4-K562 cells at 24-72 h post-infection (p.i.) (data not shown). RRV and CRW-8 growth in a4-K562 cells was inhibited by SVVYGLR and IDAPS (Fig. 3c) , the same peptides that abolished virus binding to a4 integrins (Fig. 2) . Thus, although SA11, RRV, Wa and RV-5 all bound a4b1, only SA11 and RRV were able to utilize this binding for infection and virus growth in K562 cells. Conversely, CRW-8 interacted with a4b1 to greatly increase its infectivity, but did not use this integrin for initial cell binding.
Rotavirus usage of naturally expressed a4b1 on RD cells (Londrigan et al., 2000) was studied. P4C2 and fibronectin showed a dose-dependent blockade of RRV infectivity in RD cells, to 26±7?9 % at 10 mg ml 21 and 35±3?9 % at 160 mg ml 21 , respectively. P4C2 did not affect RRV (data not shown) or SA11 infectivity in a4 integrin-negative MA104 cells. CHO B2 cells lack a5 integrin expression, so they lost adhesion during prolonged incubation at 37 u C (Schreiner et al., 1989) . Therefore, rotavirus infectivity mediated by a4b7 was determined using a4b7-CHO K1 cells. The mean±SD of the respective SA11 and RRV titres in f.f.u. ml 21 produced at an m.o.i. of 40 in a4b7-CHO K1 cells (5800±750 and 6500±1000) were significantly higher than those in CHO K1 cells (2400±750 and 3300±850) at 16 h p.i. (t-test, P<0?0001). Wa and CRW-8 did not infect either cell line. Thus, binding of SA11 and RRV, but not Wa, to a4b7 resulted in increased infectivity in CHO cells.
Rotaviruses did not utilize a9b1 for cell attachment or entry SA11, RRV and CRW-8 did not use recombinant a9b1 for K562 cell infection (Fig. 3b) or replication (Fig. 4a, lower  panel) . SA11 (Fig. 4a, upper panel) and Wa (data not shown) did not bind a9b1. Caco-2 cell expression of a9 was detected by flow cytometry with anti-a9 mAb Y9A2 (data not shown). This antibody did not affect SA11, RRV and Wa infection of Caco-2 cells, and peptide SVVYGLR did not affect SA11 infection of Caco-2 cells (Fig. 4b) . Thus, a9b1 was not a rotavirus receptor or entry co-factor. Activation of b1 increased SA11 growth in a4-K562 cells Activating antibodies induce integrins into high affinity states for ligand binding. Eosinophil resistance to a4b1-mediated detachment from VCAM-1 and MAdCAM-1 is increased by activating anti-b1 antibody 8A2 (Sriramarao et al., 2000) . To determine if b1 activation affects rotavirusa4b1 interactions, SA11 replication was measured in a4-K562 cells that had been treated with 8A2 at the concentration (0?1-0?2 mg ml 21 ) previously shown to increase K562 cell binding to fibronectin (Faull et al., 1996) and SA11 binding to a2b1 . Activation of b1 increased SA11 yield from a4-K562 cells by 50-70 % at 1 and 24 h p.i. (Fig. 5a) . Thus, rotavirus infectivity was enhanced by a4b1 activation.
Mutation of LDVT in VP7 of SA11 did not affect a4b1 recognition
The minimal active site of the dominant a4b1-binding region in fibronectin is LDV, which is totally dependent on its Asp residue (Komoriya et al., 1991) . The role of VP7 LDVT sequence in rotavirus replication was directly analysed using an SA11 variant, V-SA11-A10 II , which has a single mutation in the Asp residue of the LDVT sequence (D238N) (Lazdins et al., 1995) . Similarly to SA11, V-SA11-A10 II (Basora et al., 1998) . Rotavirus infectious titres are expressed as a percentage of the titres in the absence of any treatment. Positive controls were anti-a2 antibody AK7 (upper panel), and the DGEA peptide that is inhibitory to rotavirus usage of a2b1 (lower panel). replicated to a higher titre in a4-K562 and a2-K562 cells than in control a3-K562 cells, so VP7 LDVT was not required for SA11 usage of a4b1 or a2b1 (Fig. 5b) . V-SA11-A10 II grew to a 10-fold higher titre than SA11 in these K562 cells. This might be directly related to the LNVT mutation, but the possibility that other viral genes are involved cannot be ruled out.
Domains and sequence of the a4-subunit required for rotavirus binding
The a4 domains crucial for rotavirus binding were located using swapping mutagenesis. Predicted protruding loops at or near a4b1 sites necessary for natural ligand binding were replaced with corresponding a5 regions (Higgins et al., 2000; Irie et al., 1997) . Rotaviruses do not bind a5b1. Therefore, if the swapped a4 region is necessary for virus binding, swapping to the a5 region will prevent virus binding to a4. The region swapping will affect virus binding only if the exchanged regions are sufficiently distinct in sequence. The R3b and R3c domains are conservative in sequence between a4 and a5. The only point mutations in the putative ligandbinding region of a4 (aa 108-268) of 61 tested that abolish natural a4 ligand binding are non-conservative and located in R2 (Y120/G130), R3b (Y187) and R3c (G190) (Higgins et al., 2000; Irie et al., 1995 Irie et al., , 1997 . As shown in Fig. 6 , a4 was detected at similar levels on all CHO cell lines transfected to express these swapping and point mutations in a4, using anti-a4 antibody P4G9 that maps to an epitope outside the swapped domains (Irie et al., 1997; Kamata et al., 1995) . Binding of RRV, SA11 and Wa to a4b1 on CHO B2 cells was abolished by swapping R2 or R4, but was unaffected by swapping R1, R3a, R3b, R3c or R5 (Fig. 7) . The point mutations eliminated Wa, RRV and SA11 binding to a4b1. CRW-8 did not bind a4b1 on any cell line tested, showing the specificity of the Wa, SA11 and RRV binding (Fig. 7) . CS-1 peptide, VCAM-1 and MAdCAM-1 also required a4 R2 and R4, but not R1, R3a, R3b, R3c or R5 for binding (Higgins et al., 2000; Irie et al., 1997) . Thus, the same a4 regions and amino acids are critical for a4 binding by both rotaviruses and these natural a4 ligands.
DISCUSSION
In this study, the repertoire of integrins used by rotaviruses for cell-binding and post-binding interactions was extended to include a4b7, an intestinal homing receptor crucial for protective immune responses. It was shown for the first time that human rotaviruses bind a4b1 and a4b7, and rotaviruses require the same a4 residues for binding as natural a4 ligands. Three modes of rotavirus interactions with a4 integrins were identified. Firstly, SA11 (and RRV) uses a4b1 and a4b7 as receptors, resulting in K562 and CHO K1 cell infection. Secondly, Wa and RV-5 bind a4b1 but fail to infect K562 cells expressing a4b1. Thirdly, CRW-8 infectivity in K562 cells is greatly increased by a4b1 expression, but CRW-8 appears to use a4b1 as a co-entry factor rather than a receptor. The latter two modes have not been demonstrated previously.
A further novel finding is the likely involvement of the conserved VP5* YGL sequence in a4 recognition by rotaviruses. The peptide SVVYGLR inhibited a4b1 and a4b7 binding by rotaviruses and virus infectivity, and a4b1 binding by rotaviruses segregated with VP4 in reassortants. It is proposed that VP4 binds a4b1 using YGL. In the X-ray crystallographic structure of RRV VP5* containing aa 252-523 (VP5CT), most of the Tyr residue in the YGL sequence is exposed on the surface (Dormitzer et al., 2004) . The shorter sequence SVVYG is sufficient to mediate adhesion to a4 integrins (Gao et al., 2004) . Possibly, exposure of the Tyr and Gly residues in YGL may be sufficient for binding. The YGL sequence might become accessible through opening of a possible diglycine hinge in overlying b-sheets (Dormitzer et al., 2004) .
The VP5* IDA sequence was not necessary for a4 integrin binding by rotaviruses, consistent with the IDA location in a predicted heptad repeat region that may be inaccessible (Bremont et al., 1992; Lopez et al., 1991) . Peptide IDAPS elimination of rotavirus binding to a4 integrins probably occurred via non-IDA viral sequence, similarly to IDAPS inhibition of fibronectin binding to a4 through EILDVP mimicry (Sharma et al., 1999) . SVVYGLR and EILDVP peptides compete for a4b1 binding, and have similar affinities for a4b1 (Barry et al., 2000) . As SVVYGLR, IDAPS and EILDVP peptides inhibit ligand binding through related a4 regions, the differential effects of these peptides on rotavirus binding and infection probably relate to sequence differences in parts of the peptides with portions of the a4-binding regions in rotavirus. The VP7 LDV sequence was not involved in a4 integrin binding, as the presence of LDVT, LDVT mutation and EILDVP blockade did not affect a4 interactions with rotaviruses. This lack of inhibition by EILDVP also suggests that the VP7 LDI is not necessary for a4 recognition by rotaviruses.
Anti-VP5* mAb 2G4, and anti-VP7 antibodies RV-4 : 2 and F45 : 2, inhibited rotavirus-a4b1 binding to a titre similar to their neutralization titres. Acute-and convalescent-phase sera from children with gastroenteritis also specifically inhibited Wa binding to a4b1 (K. L. Graham, F. E. Fleming, P. Halasz, Y. Takada and B. S. Coulson, unpublished results) . These findings support the proposed roles for VP4 and VP7 in a4b1 recognition by rotaviruses.
Rotavirus usage of a4 integrins but not a9b1 was unexpected, as SVVYGLR is a common ligand for these integrins. Mutation of the SVVYGLR peptide showed that Leu and Tyr are important for a4 binding (Green et al., 2001) , whereas the Tyr appears to be critical for a9b1 binding (Yokosaki et al., 1999) . The first Val has a role in a4 binding, and mutation of the Arg increased activity against a4b1 but reduced activity against a4b7 (Green et al., 2001) . Non-conservative amino acid changes for the Val and Arg adjacent to YGL in VP5* could prevent a9b1 binding by rotaviruses.
It is at present unclear how rotavirus interactions with a4 fit with current models of rotavirus cell entry. SA11 and RRV binding to a4b1 and a4b7 may facilitate virus cell entry by endocytosis or direct membrane penetration (Lopez & Arias, 2004) , as proposed previously for rotavirus usage of other integrins . Human rotavirus binding to a4 might affect cellular functions that relate to antirotaviral responses, without facilitating infection. CRW-8 cell binding is independent of cellular protein synthesis (Jolly et al., 2001) , and OSU, another porcine rotavirus of the same P serotype as CRW-8, binds ganglioside GM3 (Rolsma et al., 1998) . Therefore, CRW-8 may bind GM3, facilitating usage of a4 integrins in a co-receptor role that results in cell entry. The identification of several possible modes of rotavirus interactions with a4 in this study will allow further dissection of the mechanisms by which different rotaviruses utilize these integrins.
The adjacent R2, R3b, R3c and R4 loops of a4 in the upper face of the predicted b-propeller structure of the integrin head were critical for rotavirus a4 recognition. However, loops R1 and R5 that are located distal from R2, R3b R3c and R4 on the upper or lower face, respectively (Higgins et al., 2000 ; Irie et al., 1997; Springer, 1997), were not involved in rotavirus a4 binding. The a4 loops required for binding by rotaviruses, MAdCAM-1, fibronectin and VCAM-1 are, therefore, identical (Higgins et al., 2000; Irie et al., 1995 Irie et al., , 1997 . Judging from their predicted positions, these loops are highly exposed on the head of activated a4 and ideally placed to mediate binding to rotaviruses and natural ligands. The increased rotavirus infectivity after a4b1 activation supports this conclusion.
This binding of rotaviruses to a4 integrins through the same a4 domains as natural ligands strongly suggests that virus a4 binding is likely to affect the functions of these competing ligands. The blockade of rotavirus a4 binding by SVVYGLR reinforces this conclusion, as SVVYGLR completely inhibits a4b7 binding to MAdCAM-1 and a4b1 binding to fibronectin CS-1, and partially inhibits a4b1 binding to VCAM-1 (Green et al., 2001) . Rotavirus a4b7 binding might affect immune responses dependent on a4b7 recognition of MAdCAM-1 for intestinal homing, and modulate the protection afforded against reinfection by rotavirus-specific a4b7 hi B and T cells (Gonzalez et al., 2003; Rose et al., 1998; Rott et al., 1997; Williams et al., 1998; Youngman et al., 2002) . Potential immune modulation by rotavirus-integrin interactions is a topic for further study.
Lamina propria mesenchymal cells are the only resident gut cell known to express a4 (Choy et al., 1990; Pender et al., 2000) . Possibly, a4b1 on these cells may bind rotaviruses. Rotavirus disease may be associated with viraemia (Blutt et al., 2003) , so virus in the circulation could contact immune cells expressing a4. Rotavirus recognition of activated a4b1 might facilitate virus carriage and infection. Lymphoid cells mediate rotavirus escape from the gut (Mossel & Ramig, 2003) , which might involve virus a4 integrin binding. Rotavirus infection has been associated with encephalitis and pancreatic islet autoantibody responses (Honeyman et al., 2000) . Rotavirus a4b7 binding might disseminate virus within the intestine and to the pancreas and brain where MAdCAM-1 is also expressed. These issues are important subjects for continuing research.
